The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors approved $57 million to support 14 new comparative clinical effectiveness research studies, including studies on dementia, prostate cancer, and anxiety disorders.
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors has approved $57 million in funding for 14 clinical effectiveness research studies. The funds will support studies for a range of conditions and problems that impose high burdens on patients, caregivers, and the healthcare system, said PCORI.
The funding includes $32 million for 3 large-scale pragmatic clinical studies focused on producing results that are broadly applicable to a wide variety of patients and care:
“Like all of our pragmatic clinical studies, these new awards will help answer significant questions regarding treatment and delivery of care that are important to patients and those who care for them,” Joe Selby, MD, MPH, executive director of PCORI, said in a statement. “These large studies feature the engagement of stakeholder groups on the research team and have been judged as having a high potential to change practice and improve patients’ outcomes.”
Additional studies that will receive funding include:
Infant Mortality Increases Across US Following Dobbs Decision
October 25th 2024The Dobbs decision was associated with a 7% absolute increase in overall infant mortality—equivalent to 247 excess deaths—and a 10% increase among infants with congenital anomalies, corresponding to 204 additional deaths.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen